SUDS3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.636800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.798200E-01
Normal-vs-Stage2
7.536600E-01
Normal-vs-Stage3
1.161360E-01
Normal-vs-Stage4
5.541000E-01
Stage1-vs-Stage2
4.223800E-01
Stage1-vs-Stage3
6.017500E-02
Stage1-vs-Stage4
5.615800E-01
Stage2-vs-Stage3
8.544100E-02
Stage2-vs-Stage4
1.234610E-01
Stage3-vs-Stage4
1.188810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.934600E-01
Normal-vs-AfricanAmerican
4.680800E-01
Normal-vs-Asian
4.945400E-01
Caucasian-vs-AfricanAmerican
5.727800E-01
Caucasian-vs-Asian
4.181200E-01
AfricanAmerican-vs-Asian
9.682000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.385600E-01
Normal-vs-Female
5.486000E-01
Male-vs-Female
6.146400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.108200E-01
Normal-vs-Age(41-60Yrs)
8.810400E-01
Normal-vs-Age(61-80Yrs)
5.784000E-01
Normal-vs-Age(81-100Yrs)
8.500200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.785000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.891600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.207200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.397610E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.749200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.041600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.649200E-01
Normal-vs-Daily Drinker
7.502800E-01
Normal-vs-Weekly Drinker
1.797800E-01
Normal-vs-Occasional Drinker
6.772200E-01
Normal-vs-Social Drinker
6.933200E-01
Non Drinker-vs-Daily Drinker
7.421800E-01
Non Drinker-vs-Weekly Drinker
1.920370E-01
Non Drinker-vs-Occasional Drinker
5.299700E-02
Non Drinker-vs-Social Drinker
6.278400E-01
Daily Drinker-vs-Weekly Drinker
1.853990E-01
Daily Drinker-vs-Occasional Drinker
1.747200E-01
Daily Drinker-vs-Social Drinker
9.098600E-01
Weekly Drinker-vs-Occasional Drinker
1.013840E-02
Weekly Drinker-vs-Social Drinker
8.729600E-02
Occasional Drinker-vs-Social Drinker
1.830170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.999590E-02
Normal-vs-Grade 2
3.677400E-03
Normal-vs-Grade 3
1.981080E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.497000E-01
Grade 1-vs-Grade 3
2.619000E-01
Grade 1-vs-Grade 4
1.999590E-02
Grade 2-vs-Grade 3
4.249600E-01
Grade 2-vs-Grade 4
3.677400E-03
Grade 3-vs-Grade 4
1.981080E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.388800E-01
Normal-vs-NonDiabetic
6.586600E-01
Diabetic-vs-NonDiabetic
8.638800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.146200E-01
Normal-vs-NoPancreatitis
6.684000E-01
Pancreatitis-vs-NoPancreatitis
7.354400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.948400E-01
Normal-vs-N1
7.851600E-01
N0-vs-N1
7.137400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.535800E-01
Normal-vs-TP53-NonMutant
9.448400E-01
TP53-Mutant-vs-TP53-NonMutant
1.988030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
